Iofina (IOF) H2 2025 earnings summary

Executive summary

• Achieved record revenue, adjusted EBITDA, and crystalline iodine production in 2025, marking the seventh consecutive year of record revenue and the strongest financial results in company history.

• Expanded plant network to eight operating IOsorbⓇ facilities, with construction underway on the largest plant to date in the Permian Basin, entering a new development phase.

• Maintained a strong safety record with only one minor lost-time incident in 2025 and one in the past five years.

Financial highlights

• Revenue increased 22% year-over-year to $66.5m; adjusted EBITDA rose 56% to $11.8m (18% margin).

• Gross profit grew 36% to $18.0m (27% of revenue); profit before tax (excluding subsidies) up 75% to $8.4m.

• Post-tax earnings surged 172% to $7.9m; net cash improved by $2.3m to $5.2m.

• Average realised iodine price increased 8% to $74.02/kg.

• Capital investment totaled $8.4m, mainly for new plant construction.

Outlook and guidance

• Anticipates surpassing 1,000MT annual crystalline iodine production by end of 2026 with new Permian Basin plant.

• Expects continued growth in iodine production, revenue, and adjusted EBITDA, supported by robust market demand and firm pricing above $70/kg.

• Strategic plan targets over 2,000MT annual production in the medium term through larger plants and new core areas.